Literature DB >> 21743824

Establishment, maintenance and in vitro and in vivo applications of primary human glioblastoma multiforme (GBM) xenograft models for translational biology studies and drug discovery.

Brett L Carlson1, Jenny L Pokorny, Mark A Schroeder, Jann N Sarkaria.   

Abstract

Development of clinically relevant tumor model systems for glioblastoma multiforme (GBM) is important for advancement of basic and translational biology. One model that has gained wide acceptance in the neuro-oncology community is the primary xenograft model. This model entails the engraftment of patient tumor specimens into the flank of nude mice and subsequent serial passage of these tumors in the flank of mice. These tumors are then used to establish short-term explant cultures or intracranial xenografts. This unit describes detailed procedures for establishment, maintenance, and utilization of a primary GBM xenograft panel for the purpose of using them as tumor models for basic or translational studies.

Entities:  

Keywords:  glioblastoma; mouse models; xenograft

Mesh:

Year:  2011        PMID: 21743824      PMCID: PMC3129784          DOI: 10.1002/0471141755.ph1416s52

Source DB:  PubMed          Journal:  Curr Protoc Pharmacol        ISSN: 1934-8282


  23 in total

1.  Heterogeneous methylation of the O(6)-methylguanine-DNA methyltransferase promoter in immortalized IMR90 cell lines.

Authors:  R P Danam; S R Howell; J S Remack; T P Brent
Journal:  Int J Oncol       Date:  2001-06       Impact factor: 5.650

Review 2.  Mammalian O6-alkylguanine-DNA alkyltransferase: regulation and importance in response to alkylating carcinogenic and therapeutic agents.

Authors:  A E Pegg
Journal:  Cancer Res       Date:  1990-10-01       Impact factor: 12.701

3.  Patient tumor EGFR and PDGFRA gene amplifications retained in an invasive intracranial xenograft model of glioblastoma multiforme.

Authors:  Caterina Giannini; Jann N Sarkaria; Atsushi Saito; Joon H Uhm; Evanthia Galanis; Brett L Carlson; Mark A Schroeder; C David James
Journal:  Neuro Oncol       Date:  2005-04       Impact factor: 12.300

4.  Increased sensitivity of transforming growth factor (TGF) beta 1 null cells to alkylating agents reveals a novel link between TGFbeta signaling and O(6)-methylguanine methyltransferase promoter hypermethylation.

Authors:  H Yamada; K Vijayachandra; C Penner; A Glick
Journal:  J Biol Chem       Date:  2001-03-21       Impact factor: 5.157

5.  PTEN mutation, EGFR amplification, and outcome in patients with anaplastic astrocytoma and glioblastoma multiforme.

Authors:  J S Smith; I Tachibana; S M Passe; B K Huntley; T J Borell; N Iturria; J R O'Fallon; P L Schaefer; B W Scheithauer; C D James; J C Buckner; R B Jenkins
Journal:  J Natl Cancer Inst       Date:  2001-08-15       Impact factor: 13.506

6.  Use of an orthotopic xenograft model for assessing the effect of epidermal growth factor receptor amplification on glioblastoma radiation response.

Authors:  Jann N Sarkaria; Brett L Carlson; Mark A Schroeder; Patrick Grogan; Paul D Brown; Caterina Giannini; Karla V Ballman; Gaspar J Kitange; Abjahit Guha; Ajay Pandita; C David James
Journal:  Clin Cancer Res       Date:  2006-04-01       Impact factor: 12.531

7.  An efficient method for derivation and propagation of glioblastoma cell lines that conserves the molecular profile of their original tumours.

Authors:  Talal M Fael Al-Mayhani; Siolian L R Ball; Jing-Wei Zhao; James Fawcett; Koichi Ichimura; Peter V Collins; Colin Watts
Journal:  J Neurosci Methods       Date:  2009-01-30       Impact factor: 2.390

8.  Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens.

Authors:  Steven M Pollard; Koichi Yoshikawa; Ian D Clarke; Davide Danovi; Stefan Stricker; Roslin Russell; Jane Bayani; Renee Head; Marco Lee; Mark Bernstein; Jeremy A Squire; Austin Smith; Peter Dirks
Journal:  Cell Stem Cell       Date:  2009-06-05       Impact factor: 24.633

9.  Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR.

Authors:  Ajay Pandita; Kenneth D Aldape; Gelareh Zadeh; Abhijit Guha; C David James
Journal:  Genes Chromosomes Cancer       Date:  2004-01       Impact factor: 5.006

10.  Identification of molecular characteristics correlated with glioblastoma sensitivity to EGFR kinase inhibition through use of an intracranial xenograft test panel.

Authors:  Jann N Sarkaria; Lin Yang; Patrick T Grogan; Gaspar J Kitange; Brett L Carlson; Mark A Schroeder; Evanthia Galanis; Caterina Giannini; Wenting Wu; Eduard B Dinca; C David James
Journal:  Mol Cancer Ther       Date:  2007-03       Impact factor: 6.261

View more
  117 in total

Review 1.  Patient-Derived Xenografts as a Model System for Radiation Research.

Authors:  Christopher D Willey; Ashley N Gilbert; Joshua C Anderson; George Yancey Gillespie
Journal:  Semin Radiat Oncol       Date:  2015-05-14       Impact factor: 5.934

2.  Transcription factors NFIA and NFIB induce cellular differentiation in high-grade astrocytoma.

Authors:  Kok-Siong Chen; Caitlin R Bridges; Zorana Lynton; Jonathan W C Lim; Brett W Stringer; Revathi Rajagopal; Kum-Thong Wong; Dharmendra Ganesan; Hany Ariffin; Bryan W Day; Linda J Richards; Jens Bunt
Journal:  J Neurooncol       Date:  2019-11-23       Impact factor: 4.130

3.  Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma.

Authors:  Laura D Hover; Philip Owens; Alexander L Munden; Jialiang Wang; Lola B Chambless; Corey R Hopkins; Charles C Hong; Harold L Moses; Ty W Abel
Journal:  Neuro Oncol       Date:  2015-12-18       Impact factor: 12.300

4.  Automatic 3D Nonlinear Registration of Mass Spectrometry Imaging and Magnetic Resonance Imaging Data.

Authors:  Walid M Abdelmoula; Michael S Regan; Begona G C Lopez; Elizabeth C Randall; Sean Lawler; Ann C Mladek; Michal O Nowicki; Bianca M Marin; Jeffrey N Agar; Kristin R Swanson; Tina Kapur; Jann N Sarkaria; William Wells; Nathalie Y R Agar
Journal:  Anal Chem       Date:  2019-04-22       Impact factor: 6.986

5.  Everolimus improves the efficacy of dasatinib in PDGFRα-driven glioma.

Authors:  Zachary Miklja; Viveka Nand Yadav; Rodrigo T Cartaxo; Ruby Siada; Chase C Thomas; Jessica R Cummings; Brendan Mullan; Stefanie Stallard; Alyssa Paul; Amy K Bruzek; Kyle Wierzbicki; Tao Yang; Taylor Garcia; Ian Wolfe; Marcia Leonard; Patricia L Robertson; Hugh Jl Garton; Daniel R Wahl; Hemant Parmar; Jann N Sarkaria; Cassie Kline; Sabine Mueller; Theodore Nicolaides; Chana Glasser; Sarah Es Leary; Sriram Venneti; Chandan Kumar-Sinha; Arul M Chinnaiyan; Rajen Mody; Manjunath P Pai; Timothy N Phoenix; Bernard L Marini; Carl Koschmann
Journal:  J Clin Invest       Date:  2020-10-01       Impact factor: 14.808

Review 6.  RNA interference for glioblastoma therapy: Innovation ladder from the bench to clinical trials.

Authors:  Eunice L Lozada-Delgado; Nilmary Grafals-Ruiz; Pablo E Vivas-Mejía
Journal:  Life Sci       Date:  2017-08-31       Impact factor: 5.037

7.  Immunovirotherapy with measles virus strains in combination with anti-PD-1 antibody blockade enhances antitumor activity in glioblastoma treatment.

Authors:  Jayson Hardcastle; Lisa Mills; Courtney S Malo; Fang Jin; Cheyne Kurokawa; Hirosha Geekiyanage; Mark Schroeder; Jann Sarkaria; Aaron J Johnson; Evanthia Galanis
Journal:  Neuro Oncol       Date:  2017-04-01       Impact factor: 12.300

8.  Carbenoxolone enhances TRAIL-induced apoptosis through the upregulation of death receptor 5 and inhibition of gap junction intercellular communication in human glioma.

Authors:  Yulyana Yulyana; Berwini B Endaya; Wai H Ng; Chang M Guo; Kam M Hui; Paula Y P Lam; Ivy A W Ho
Journal:  Stem Cells Dev       Date:  2013-03-26       Impact factor: 3.272

9.  Quantitative Phosphoproteomics Reveals Wee1 Kinase as a Therapeutic Target in a Model of Proneural Glioblastoma.

Authors:  Rebecca S Lescarbeau; Liang Lei; Katrina K Bakken; Peter A Sims; Jann N Sarkaria; Peter Canoll; Forest M White
Journal:  Mol Cancer Ther       Date:  2016-05-17       Impact factor: 6.261

Review 10.  Gene therapy for brain tumors: basic developments and clinical implementation.

Authors:  Hikmat Assi; Marianela Candolfi; Gregory Baker; Yohei Mineharu; Pedro R Lowenstein; Maria G Castro
Journal:  Neurosci Lett       Date:  2012-08-10       Impact factor: 3.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.